Literature DB >> 18830659

[Steps towards a symptom-based diagnosis of fibromyalgia syndrome. Symptom profiles of patients from different clinical settings].

W Häuser1, I Akritidou, E Felde, S Klauenberg, C Maier, A Hoffmann, V Köllner, A Hinz.   

Abstract

BACKGROUND: A symptom-based diagnosis of fibromyalgia syndrome (FMS) without tender point examination is helpful for primary medical care. We tested whether a symptom-based diagnosis of FMS can be based on the symptoms of musculoskeletal pain and fatigue.
METHODS: The most frequent and severe symptoms in FMS patients from four different settings (n= 464 from a self-help organization, n=162 from medical expertise, n= 33 from a private rheumatology practice, n=36 from a tertiary-care pain department) were assessed using the Giessen Subjective Complaints List GBB 24. The most frequent and severe symptoms were assessed and compared to those of a representative German population sample. A k-means cluster analysis was performed to identify sub-groups with and without additional vegetative symptoms within the total sample of FMS patients.
RESULTS: The most frequent and severe symptoms in all four sub-samples were low back pain, limb pain and fatigue. The greatest mean differences between FMS patients and the general population were found in the subscales "limb pain" and "fatigue". Cluster analysis identified three sub-groups of patients which were all characterized by severe limb pain and fatigue, as well as varying degrees of vegetative symptoms.
SUMMARY: Following the exclusion of inflammatory rheumatoid, endocrinological and neurological diseases, a symptom-based clinical diagnosis of FMS can be based on of the key symptoms of chronic widespread musculoskeletal pain, as well as chronic fatigue.

Entities:  

Mesh:

Year:  2008        PMID: 18830659     DOI: 10.1007/s00393-008-0327-0

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  18 in total

1.  The relation between tender points and fibromyalgia symptom variables: evidence that fibromyalgia is not a discrete disorder in the clinic.

Authors:  F Wolfe
Journal:  Ann Rheum Dis       Date:  1997-04       Impact factor: 19.103

Review 2.  Is fibromyalgia a distinct clinical entity? The clinical investigator's evidence.

Authors:  I J Russell
Journal:  Baillieres Best Pract Res Clin Rheumatol       Date:  1999-09       Impact factor: 4.098

Review 3.  Is fibromyalgia a distinct clinical entity? The epidemiologist's evidence.

Authors:  M O Mäkelä
Journal:  Baillieres Best Pract Res Clin Rheumatol       Date:  1999-09       Impact factor: 4.098

4.  Fibromyalgia diagnosis: a comparison of clinical, survey, and American College of Rheumatology criteria.

Authors:  Robert S Katz; Frederick Wolfe; Kaleb Michaud
Journal:  Arthritis Rheum       Date:  2006-01

Review 5.  [Generalized tendomyopathy. I: Clinical aspects, follow-up and differential diagnosis].

Authors:  W Müller; J Lautenschläger
Journal:  Z Rheumatol       Date:  1990 Jan-Feb       Impact factor: 1.372

6.  Medically unexplained physical symptoms, anxiety, and depression: a meta-analytic review.

Authors:  Peter Henningsen; Thomas Zimmermann; Heribert Sattel
Journal:  Psychosom Med       Date:  2003 Jul-Aug       Impact factor: 4.312

7.  [What are the key symptoms of fibromyalgia? Results of a survey of the German Fibromyalgia Association].

Authors:  W Häuser; C Zimmer; E Felde; V Köllner
Journal:  Schmerz       Date:  2008-04       Impact factor: 1.107

Review 8.  Management of functional somatic syndromes.

Authors:  Peter Henningsen; Stephan Zipfel; Wolfgang Herzog
Journal:  Lancet       Date:  2007-03-17       Impact factor: 79.321

9.  Fibromyalgia syndrome.

Authors:  Philip Mease; Lesley M Arnold; Robert Bennett; Annelies Boonen; Dan Buskila; Serena Carville; Amy Chappell; Ernest Choy; Daniel Clauw; Dina Dadabhoy; Michael Gendreau; Don Goldenberg; Geoffrey Littlejohn; Susan Martin; Philip Perera; I Jon Russell; Lee Simon; Michael Spaeth; David Williams; Leslie Crofford
Journal:  J Rheumatol       Date:  2007-06       Impact factor: 4.666

10.  An internet survey of 2,596 people with fibromyalgia.

Authors:  Robert M Bennett; Jessie Jones; Dennis C Turk; I Jon Russell; Lynne Matallana
Journal:  BMC Musculoskelet Disord       Date:  2007-03-09       Impact factor: 2.362

View more
  7 in total

1.  [Psychosomatic aspects in orthopedics].

Authors:  V Köllner; S Rupp
Journal:  Orthopade       Date:  2012-02       Impact factor: 1.087

2.  [Fibromyalgia syndrome. Definition, classification, clinical diagnosis and prognosis].

Authors:  W Eich; W Häuser; B Arnold; W Jäckel; M Offenbächer; F Petzke; M Schiltenwolf; M Settan; C Sommer; T Tölle; N Uçeyler; P Henningsen
Journal:  Schmerz       Date:  2012-06       Impact factor: 1.107

3.  [Effects of a cognitive-behavioral patient education on fibromyalgia: a controlled efficacy study].

Authors:  M Lange; B Krohn-Grimberghe; F Petermann
Journal:  Z Rheumatol       Date:  2011-06       Impact factor: 1.372

4.  Identification of symptom and functional domains that fibromyalgia patients would like to see improved: a cluster analysis.

Authors:  Robert M Bennett; Jon Russell; Joseph C Cappelleri; Andrew G Bushmakin; Gergana Zlateva; Alesia Sadosky
Journal:  BMC Musculoskelet Disord       Date:  2010-06-28       Impact factor: 2.362

5.  Applying the ACR Preliminary Diagnostic Criteria in the Diagnosis and Assessment of Fibromyalgia.

Authors:  So Mi Kim; Sang Heon Lee; Hae Rim Kim
Journal:  Korean J Pain       Date:  2012-06-28

6.  Distinguishing fibromyalgia from rheumatoid arthritis and systemic lupus in clinical questionnaires: an analysis of the revised Fibromyalgia Impact Questionnaire (FIQR) and its variant, the Symptom Impact Questionnaire (SIQR), along with pain locations.

Authors:  Ronald Friend; Robert M Bennett
Journal:  Arthritis Res Ther       Date:  2011-04-08       Impact factor: 5.156

7.  Identifying the symptom and functional domains in patients with fibromyalgia: results of a cross-sectional Internet-based survey in Italy.

Authors:  Fausto Salaffi; Flavio Mozzani; Antonella Draghessi; Fabiola Atzeni; Rosita Catellani; Alessandro Ciapetti; Marco Di Carlo; Piercarlo Sarzi-Puttini
Journal:  J Pain Res       Date:  2016-05-13       Impact factor: 3.133

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.